Insulet (PODD) EBT Growth (1y) (2011 - 2026)
Insulet (PODD) EBT Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn | -29.12% |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn | 53.94% |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 45.44% |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn | 12.65% |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 29.89% |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn | 31.69% |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn | 13.05% |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 71.38% |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn | 17.94% |
| 10 | Insulet | 10.34 Bn | 9.80 Bn | 562.60 Mn | 317.96% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 317.96% |
| Mar 31, 2026 | 134.44% |
| Dec 31, 2025 | 25.85% |
| Sep 30, 2025 | 48.13% |
| Jun 30, 2025 | -44.42% |
| Mar 31, 2025 | -12.20% |
| Dec 31, 2024 | 3.24% |
| Sep 30, 2024 | 54.38% |
| Jun 30, 2024 | 79.30% |
| Mar 31, 2024 | 123.17% |
| Dec 31, 2023 | 383.86% |
| Sep 30, 2023 | 1,042.11% |
| Jun 30, 2023 | 178.95% |
| Mar 31, 2023 | -16.04% |
| Dec 31, 2022 | -33.23% |
| Sep 30, 2022 | -137.50% |
| Jun 30, 2022 | -27.11% |
| Mar 31, 2022 | 9,666.67% |
| Dec 31, 2021 | 280.54% |
| Sep 30, 2021 | 13.43% |